AlzeCure Pharma AB (publ) (STO:ALZCUR)

AlzeCure Pharma AB Balance Sheet

Financials in millions SEK. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	50.34	31.5	29.1	25.58	41.74
Cash & Short-Term Investments	50.34	31.5	29.1	25.58	41.74
Cash Growth	59.81%	8.24%	13.77%	-38.73%	-62.88%
Accounts Receivable	-	0.04	-	-	-
Other Receivables	3.34	1.77	1.47	1.38	1.54
Receivables	3.34	1.8	1.47	1.38	1.54
Prepaid Expenses	1.2	0.61	1.04	0.55	0.92
Other Current Assets	0.09	-	-	-	-
Total Current Assets	54.96	33.9	31.61	27.51	44.2
Property, Plant & Equipment	4.06	5.33	0.38	0.85	1.42
Other Intangible Assets	0.02	0.02	0.02	0.02	0.02
Other Long-Term Assets	-0	-	-	42.46	0.01
Total Assets	59.04	39.25	32	70.84	45.65
Accounts Payable	4.16	2.69	2.69	4.85	5.97
Accrued Expenses	6.67	5.25	4.95	5.18	6.38
Other Current Liabilities	12.74	1.61	0.59	0.33	0.32
Total Current Liabilities	23.56	9.55	8.23	10.35	12.67
Long-Term Leases	2.56	3.64	-	-	-
Total Liabilities	26.12	13.18	8.23	10.35	12.67
Common Stock	2.87	2.21	1.55	1.27	0.94
Additional Paid-In Capital	453.27	399.43	362.44	361.98	278.84
Retained Earnings	-423.22	-375.57	-340.22	-303.05	-246.81
Comprehensive Income & Other	-	-	-	0.28	-
Shareholders' Equity	32.92	26.07	23.77	60.48	32.97
Total Liabilities & Equity	59.04	39.25	32	70.84	45.65
Total Debt	2.56	3.64	-	-	-
Net Cash (Debt)	47.78	27.86	29.1	25.58	41.74
Net Cash Growth	71.47%	-4.25%	13.77%	-38.73%	-62.88%
Net Cash Per Share	0.48	0.36	0.47	0.54	1.11
Filing Date Shares Outstanding	114.91	88.3	62.09	62.09	37.77
Total Common Shares Outstanding	114.91	88.3	62.09	62.09	37.77
Working Capital	31.4	24.36	23.38	17.15	31.53
Book Value Per Share	0.29	0.30	0.38	0.97	0.87
Tangible Book Value	32.9	26.05	23.76	60.47	32.96
Tangible Book Value Per Share	0.29	0.30	0.38	0.97	0.87
Machinery	3.02	3.02	2.9	2.9	2.9

Source: S&P Global Market Intelligence. Standard template. Financial Sources.